Endovascular recanalization for non-acute MCA occlusion is technically feasible in reasonably selected patients, especially type I patients, and has potential as an alternative option for patients with recurrent stroke or transient ischemic attack in the short term despite optimal medical therapy.
Keyphrases
- middle cerebral artery
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- liver failure
- peritoneal dialysis
- prognostic factors
- aortic dissection
- atrial fibrillation
- risk assessment
- respiratory failure
- drug induced
- oxidative stress
- internal carotid artery
- bone marrow
- climate change
- extracorporeal membrane oxygenation
- cell therapy
- human health
- brain injury
- acute respiratory distress syndrome
- replacement therapy